Citadel Advisors - LEGEND BIOTECH CORP ownership

LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 140 filers reported holding LEGEND BIOTECH CORP in Q1 2022. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of LEGEND BIOTECH CORP
ValueSharesWeighting
Q3 2023$2,764,381
-22.1%
41,155
-20.0%
0.00%
-100.0%
Q2 2023$3,548,970
+93.7%
51,412
+35.3%
0.00%
Q1 2023$1,832,408
-61.8%
38,001
-60.5%
0.00%
-100.0%
Q4 2022$4,796,963
-64.6%
96,093
-71.1%
0.00%
-50.0%
Q3 2022$13,549,000
+7.3%
332,076
+44.6%
0.00%
-33.3%
Q2 2022$12,629,000
+151.7%
229,609
+66.3%
0.00%
+200.0%
Q1 2022$5,018,000
+134.7%
138,065
+200.9%
0.00%
Q4 2021$2,138,000
-75.6%
45,880
-73.5%
0.00%
-100.0%
Q3 2021$8,768,000
+112.5%
173,425
+72.5%
0.00%
+100.0%
Q2 2021$4,127,000
-76.5%
100,561
-83.4%
0.00%
-75.0%
Q1 2021$17,574,000
+163.7%
605,614
+155.9%
0.00%
+100.0%
Q4 2020$6,664,000
-29.3%
236,649
-22.5%
0.00%
-33.3%
Q3 2020$9,421,000
+629.2%
305,176
+905.2%
0.00%
Q2 2020$1,292,00030,3590.00%
Other shareholders
LEGEND BIOTECH CORP shareholders Q1 2022
NameSharesValueWeighting ↓
FengHe Fund Management Pte. Ltd. 526,072$21,595,00011.36%
Consonance Capital Management LP 1,647,497$67,630,0008.14%
Johnson & Johnson Innovation - JJDC, Inc. 1,629,173$66,878,0006.84%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 1,342,442$55,107,0002.29%
Vivo Capital, LLC 956,702$39,273,0001.70%
Hudson Bay Capital Management LP 1,878,374$77,107,0000.93%
Capital International Sarl 220,470$9,050,0000.78%
Capital International, Inc./CA/ 1,951,845$80,123,0000.72%
Avidity Partners Management LP 625,000$25,656,0000.69%
INDUS CAPITAL PARTNERS, LLC 94,678$3,887,0000.66%
View complete list of LEGEND BIOTECH CORP shareholders